Sun Life Financial’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-86
Closed -$17K 409
2021
Q1
$17K Hold
86
﹤0.01% 302
2020
Q4
$18K Sell
86
-1
-1% -$199 ﹤0.01% 273
2020
Q3
$15K Buy
87
+2
+2% +$369 ﹤0.01% 283
2020
Q2
$16K Sell
85
-1
-1% -$164 ﹤0.01% 239
2020
Q1
$13K Buy
86
+2
+2% +$319 ﹤0.01% 236
2019
Q4
$13K Sell
84
-33
-28% -$4.76K ﹤0.01% 284
2019
Q3
$16K Buy
117
+2
+2% +$262 ﹤0.01% 431
2019
Q2
$14K Sell
115
-129
-53% -$14.3K ﹤0.01% 450
2019
Q1
$25K Sell
244
-150
-38% -$15.5K 0.01% 460
2018
Q4
$45K Buy
394
+2
+0.5% +$214 0.01% 403
2018
Q3
$45K Buy
392
+5
+1% +$548 0.01% 455
2018
Q2
$40K Buy
387
+323
+505% +$32.7K 0.01% 467
2018
Q1
$649 Sell
64
-247
-79% -$23.3K 0.01% 391
2017
Q4
$26K Sell
311
-739
-70% -$61.1K ﹤0.01% 392
2017
Q3
$81K Buy
+1,050
New +$80.3K 0.01% 385

Other funds holding RMD

Sun Life Financial's RMD Position: Q2 2021 in Review

Sun Life Financial sold out of ResMed (RMD) in Q2 2021, closing a stake of 86 shares — an estimated $17K sold.

Sun Life Financial first reported a position in RMD in Q3 2017 and held it in 15 quarters. The position peaked at $81K in Q3 2017. 661 funds tracked by Wall St. Rank hold RMD as of Q2 2021.

  • Sun Life Financial reported no remaining ResMed position as of Q2 2021 after selling out during the quarter.
  • Sun Life Financial sold 86 ResMed shares in Q2 2021, an estimated $17K.
  • Sun Life Financial first reported a position in ResMed in Q3 2017 and held it in 15 quarters.
  • Sun Life Financial's ResMed position peaked at $81K in Q3 2017.
  • 661 funds tracked by Wall St. Rank held ResMed as of Q2 2021.

Based on Sun Life Financial's 13F filing for Q2 2021, filed 10 Aug 2021.